Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Andrologia ; 50(2)2018 Mar.
Article in English | MEDLINE | ID: mdl-28752522

ABSTRACT

Pentoxifylline (PF) is a xanthine derivative drug primarily used to treat peripheral vascular disorders. It is currently used in assisted reproductive technologies to enhance human sperm motility. However, the mechanism by which this enhancement occurs is not fully understood. Given that nitric oxide has been identified as a trigger to sperm motion, we asked whether nitric oxide modulates the stimulatory effect of PF on sperm motility. A total of 41 semen samples from infertile males were studied. Nitric oxide production in the presence of 5 mm PF was tested using different bio-analytical methods (spectrophotometry, fluorometry and fluorescence microscopy). The spectrophotometric determination showed higher levels of nitrite, an indirect measure for nitric oxide, in sperm samples supplemented with PF compared to controls. The fluorometric experiment showed higher 4, 5-diaminofluorescein triazole, a product from the reaction between nitric oxide and 4, 5-diaminofluorescein diacetate, after adding PF to spermatozoa. The fluorescence microscopy images of the spermatozoa supplemented with PF showed higher green fluorescence, indicating higher 4, 5-diaminofluorescein triazole levels, compared to controls. It is concluded that PF enhances nitric oxide production in human spermatozoa, which explains, at least in part, the mechanism by which PF stimulates human sperm motility.


Subject(s)
Infertility, Male/physiopathology , Nitric Oxide/biosynthesis , Pentoxifylline/pharmacology , Sperm Motility/drug effects , Spermatozoa/physiology , Humans , Infertility, Male/drug therapy , Male , Microscopy, Fluorescence , Nitrites/analysis , Pentoxifylline/therapeutic use , Spectrophotometry , Spermatozoa/drug effects
2.
Andrologia ; 50(1)2018 Feb.
Article in English | MEDLINE | ID: mdl-28752572

ABSTRACT

Several published studies, both direct and indirect, have connected paracetamol, also named acetaminophen, a commonly used over-the-counter analgesic and antipyretic medication, with semen quality and male infertility, although as yet this connection is unclear. This review addresses the effect of paracetamol on semen quality and hence on male factor infertility. We searched the MEDLINE database from January 1980 through January 2017 for English-language articles using the key words "paracetamol" and "acetaminophen" versus "sperm." References from articles were used only if relevant. In summary, paracetamol, when used at high doses, appears to change semen quality, particularly sperm morphology, and hence its fertilising ability. Such effect of paracetamol on semen quality may occur by suppressing testosterone synthesis, inducing oxidative stress, provoking apoptosis of spermatocytes, reducing nitric oxide production and inhibiting prostaglandin synthesis. Further research, particularly clinical research, will be very important to confirm these effects.


Subject(s)
Acetaminophen/pharmacology , Analgesics, Non-Narcotic/pharmacology , Oxidative Stress/drug effects , Semen/drug effects , Spermatozoa/drug effects , Cell Shape/drug effects , Humans , Male , Semen/cytology , Semen/metabolism , Semen Analysis , Spermatozoa/cytology , Spermatozoa/metabolism
3.
Andrologia ; 49(4)2017 May.
Article in English | MEDLINE | ID: mdl-27444248

ABSTRACT

Various studies (direct and indirect) have presented the effect of captopril, a universally used antihypertensive medication, on semen quality; yet, this effect is still collectively unreviewed. This review systematically discusses and summarises the effect of captopril on semen quality. We searched all published articles in the MEDLINE electronic database since June 1985 until January 2016 using the keywords "captopril" and "sperm," and certain supporting articles were reviewed and considered, if relevant. In conclusion, up to the present time, captopril does not appear to induce a striking change in semen quality, and hence on male infertility, while it may affect the rate of spermatozoa-egg fusion as it inhibits the activity of angiotensin-converting enzyme that is released during capacitation and the acrosome reaction. Further research, mainly clinical, is still desired to prove these effects.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/adverse effects , Captopril/adverse effects , Hypertension/drug therapy , Semen/drug effects , Sperm Motility/drug effects , Spermatozoa/drug effects , Acrosome Reaction/drug effects , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Captopril/therapeutic use , Gonadal Steroid Hormones/blood , Humans , Infertility, Male/chemically induced , Kallikrein-Kinin System/drug effects , Male , Oxidative Stress/drug effects , Peptidyl-Dipeptidase A/metabolism , Semen/enzymology , Sperm Capacitation/drug effects
4.
Andrologia ; 48(5): 603-4, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26395279

ABSTRACT

Creatine kinase enzyme (CK) is indispensable for sperm function because it catalyses the regeneration of ATP from the chemical shuttle between creatine and creatine phosphate. Here, we measured CK activity of human spermatozoa in the presence of pentoxifylline (PF), a xanthine derivative drug primarily used to treat peripheral vascular function. Nine semen samples from different males were subjected to swim up, incubated with PF and tested for CK activity using the kinetic spectrophotometric method. The CK activity of spermatozoa significantly increased after addition of PF at 5 mm compared with the control (with 0.0 mm PF). Given that PF has been identified as a sperm motility enhancer and that CK is crucial for adequate sperm motion; then, the aptitude of PF to enhance sperm motility may be modulated by increasing CK activity.


Subject(s)
Creatine Kinase/metabolism , Pentoxifylline/pharmacology , Semen/drug effects , Semen/enzymology , Humans , In Vitro Techniques , Kinetics , Male , Sperm Motility/drug effects , Spermatozoa/drug effects , Spermatozoa/enzymology
5.
Nutr Res ; 34(10): 862-7, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25223711

ABSTRACT

Although the effects of pomegranate juice (PJ) on type 2 diabetic (T2D) conditions have been reported, a clinical study focusing on the short-term effects on different diabetic variables is still needed. We hypothesized that PJ consumption by T2D patients could reduce their insulin-resistant state and decrease their fasting serum glucose (FSG) levels, 3 hours after juice ingestion. This study demonstrated the direct effect of fresh PJ on FSG and insulin levels in T2D patients. Blood samples from 85 participants with type 2 diabetes were collected after a 12-hour fast, then 1 and 3 hours after administration of 1.5 mL of PJ, per kg body weight. Serum glucose was measured based on standard methods using the BS-200 Chemistry Analyzer (Shenzhen Mindray Bio-Medical Electronics Co Ltd, Shenzhen, China). Commercially available immunoassay kits were used to measure human insulin. Generally, the results demonstrated decreased FSG, increased ß-cell function, and decreased insulin resistance among T2D participants, 3 hours after PJ administration (P < .05). This hypoglycemic response depended on initial FSG levels, as participants with lower FSG levels (7.1-8.7 mmol/L) demonstrated a greater hypoglycemic response (P < .05) compared with those who had higher FSG levels (8.8-15.8 mmol/L). The effect of PJ was also not affected by the sex of the patient and was less potent in elderly patients. In conclusion, this work offers some encouragement for T2D patients regarding PJ consumption as an additional contribution to control glucose levels.


Subject(s)
Blood Glucose/metabolism , Diabetes Mellitus, Type 2/diet therapy , Insulin Resistance , Insulin-Secreting Cells/drug effects , Insulin/blood , Lythraceae , Phytotherapy , Adult , Beverages , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/drug therapy , Fasting , Female , Fruit , Humans , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/therapeutic use , Male , Middle Aged , Plant Preparations/pharmacology , Plant Preparations/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL